12 research outputs found
A phase II, multicenter study to evaluate the efficacy and safety using autologous tumor infiltrating lymphocytes (LN-145) in patients with recurrent, metastatic, or persistent cervical carcinoma
Adverse events and responses in patients with recurrent ovarian cancer undergoing early-phase immune checkpoint inhibitor clinical trials
BRCA1-mediated repression of select X chromosome genes
10.1186/1479-5876-2-32Journal of Translational Medicine